GSK

GSK admits to 2001 China bribery scandal

GlaxoSmithKline faces further scrutiny from US prosecutors after it emerged that staff were caught bribing Chinese officials more than a decade ago.

The news comes as US and UK authorities investigate allegations that GSK employees bribed doctors and officials more recently to boost drug sales in China.

The Financial Times has learnt that GSK uncovered problems with its China vaccine business in 2001 that led to the firing of about 30 employees.

您已閱讀15%(447字),剩餘85%(2564字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×